Sarepta Therapeutics (SRPT) PT Lowered to $270 at JMP Securities Aug 20, 2019 04:53AM
Sarepta Therapeutics (SRPT) PT Lowered to $270 at JMP Securities Jul 19, 2018 05:50AM
Sarepta Therapeutics (SRPT) Updated PT Settles At 'Street High' $275 - JMP Jun 25, 2018 06:39AM
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences Jun 5, 2018 08:30AM
Sarepta Therapeutics (SRPT) PT Lowered to $90 at JMP Securities May 4, 2018 04:08AM


Mar 12, 2018 10:53AM Sarepta Therapeutics (SRPT) PT Raised to $95 at JMP Securities
Mar 1, 2017 07:11AM Sarepta Therapeutics (SRPT) PT Lowered to $48 at JMP Securities
Jan 6, 2017 07:49AM Sarepta Therapeutics (SRPT) PT Lowered to $65 at JMP Securities Following Update, Survey; Sees Upside to ~$160
Sep 28, 2016 03:05PM Notable 52-Week Highs and Lows 9/28: (SRPT) (NVDA) (CLD) High; (FGP) (GBSN) Low
Sep 28, 2016 09:10AM Pre-Open Stock Movers 09/28: (SEED) (AVXL) (ATHX) Higher; (GALT) (TPX) (SONC) Lower (more...)
Sep 28, 2016 07:46AM Sarepta Therapeutic's (SRPT) Price Target Raised to $90 at JMP Securities
Sep 19, 2016 03:04PM JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market Outperform
May 3, 2016 10:24AM Notable Analyst Rating Changes 5/3: (MEP) (RSG) (AXTI) Upgraded; (CYH) (UTX) (SRPT) Downgraded
Mar 23, 2016 02:30PM JMP Securities Downgrades Sarepta Therapeutic (SRPT) to Market Underperform
Oct 27, 2014 11:41AM JMP Securities Downgrades Sarepta Therapeutic (SRPT) to Market Perform
Sep 24, 2014 10:45AM Notable Analyst Rating Changes 9/24: (SNX) (MRVL) (FCN) Upgraded; (UL) (MS) (ASNA) Downgraded
Sep 24, 2014 09:32AM Pre-Open Stock Movers 9/24: (LPCN) (MACK) (ACOR) Higher; (ECTE) (ATOS) (GTI) Lower (more...)
Apr 21, 2014 12:45PM Unusual 11 Mid-Day Movers 04/21: (SRPT) (CBEY) (ASTM) Higher; (MGI) (XXII) (WLT) Lower
Apr 21, 2014 11:08AM JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market Outperform
Jan 27, 2014 06:56AM JMP Securities Downgrades Sarepta Therapeutic (SRPT) to Market Perform
May 28, 2013 03:58PM Sarepta Therapeutic's (SRPT) Eteplirsen Could Have Safety Advantage
Dec 13, 2012 09:18AM Sarepta Therapeutics (SRPT) 4.95M Share Offering Priced at $25.25
Nov 12, 2012 11:02AM Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
Aug 27, 2012 11:06AM Notable Analyst Rating Changes 08/27: (WY) (MPC) (KEG) Upgraded; (LYB) (PEG) (ADSK) Downgraded